Guidelines, supported by several medical societies, offer direction for post-operative and “definitive” settings.
This week, the American Society for Radiation Oncology (ASTRO) released its first clinical guidelines for using radiation therapy to treat patients who have non-metastatic cervical cancer.
The guidelines, published in Practical Radiation Oncology, discuss best practices for using external-beam radiation therapy (EBRT) and brachytherapy in both post-operative and “definitive” settings. This guidance also touches on using chemotherapy and surgery in combination with radiation treatments, as well as intensity-modulated radiation therapy (IMRT).
"Cervical cancer treatment has advanced dramatically over the last 20 years. Increased use of intensity-modulated radiation therapy (IMRT) and image-guided brachytherapy, in particular, have resulted in better patient outcomes and fewer treatment complications," said Akila N. Viswanathan, M.D., MPH, guideline task force chair and professor and interim director of radiation oncology and molecular radiation sciences at the Johns Hopkins Sidney Kimmel Cancer Center in Baltimore. "Our intention in developing this guideline is to encourage physicians to make these approaches part of their daily practice."
A multi-disciplinary panel reviewed scientific articles published from January 1993 to October 2018 to draft the guidelines. And, several societies, including the Canadian Association of Radiation Oncology, the European Society for Radiotherapy and Oncology, and the Society of Gynecologic Oncology have endorsed them.
Specific recommendations for locally advanced cancer were:
Additionally, the guidelines conditionally recommended implementing radiation or chemoradiation in definitive setting for patients with FIGO stage IA1-IB2 cancers who are unable to undergo surgery, brachytherapy for patients with positive margins, and IMRT alongside EBRT in the definitive setting.
It is important to note, Viswanathan cautioned, that these guidelines were drafted prior to the COVID-19 pandemic so they do not address the virus or any impact it might have on cervical cancer treatment. However, the guidelines task force did caution against postponing cervical cancer treatment during the outbreak.
“Cervical cancer is one of those cancers where you just can’t wait,” she said. "You need to treat it right away in order to have the greatest chance of cure."
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 3
August 2nd 2025In the last of a three-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, share additional insights on practical considerations and potential challenges in integrating abbreviated breast MRI into clinical practice, and offer their thoughts on future research directions.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 3
August 2nd 2025In the third of a three-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, discuss strategies for maintaining the integrity of time-out procedures and communication with remote MRI scanning.
Twenty Years of CT Colonography for Colorectal Cancer Screening: What the Research Reveals
August 2nd 2025Computed tomography colonography (CTC) demonstrated a 91.6 percent positive predictive value (PPV) for polyps > 6 mm, according to new research involving over 9,000 patients who underwent CTC for primary asymptomatic colorectal cancer screening.